Basit öğe kaydını göster

dc.contributor.authorOngoren, Seniz
dc.contributor.authorKafadar, Ali
dc.contributor.authorAki, Hilal
dc.contributor.authorUzunaslan, Didem
dc.contributor.authorSaygin, Caner
dc.contributor.authorTuzuner, Nukhet
dc.contributor.authorBatur, Sebnem
dc.contributor.authorOz, Buge
dc.date.accessioned2021-03-05T18:22:03Z
dc.date.available2021-03-05T18:22:03Z
dc.date.issued2013
dc.identifier.citationAki H., Uzunaslan D., Saygin C., Batur S., Tuzuner N., Kafadar A., Ongoren S., Oz B., "Primary central nervous system lymphoma in immunocompetent individuals: a single center experience", INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, cilt.6, ss.1068-1075, 2013
dc.identifier.issn1936-2625
dc.identifier.othervv_1032021
dc.identifier.otherav_c9fa4de0-d9e3-41a8-a2d6-a3ea3c2dba66
dc.identifier.urihttp://hdl.handle.net/20.500.12627/133810
dc.description.abstractPrimary central nervous system lymphoma (PCNSL) is defined as the involvement of brain, leptomeninges, eyes or spinal cord by non-Hodgkin lymphoma. The role of various prognostic markers in predicting adverse outcome is debated. Objectives: To investigate the clinical and immunohistochemical findings of immunocompetent PCNSL cases (39 cases) diagnosed at the study center, and evaluate the influence of potential prognostic factors on overall survival (OS) of patients. Methods: Data regarding patient characteristics, neuroimaging, pathological and immunohistochemical features and follow-up were obtained from patient records. The influence of potential prognostic parameters on OS was investigated by log-rank test and Cox regression analysis. Results: Patients who received combined chemotherapy and radiotherapy had a significantly better OS when compared to chemotherapy alone. Other variables included in this study were not associated with a significant survival advantage. Conclusion: In this study, we failed to demonstrate a relationship between different clinicopathological variables and OS of patients. Prospective studies with large patient series are needed to investigate other potential prognostic factors.
dc.language.isoeng
dc.subjectPatoloji
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectPATOLOJİ
dc.subjectBiyoloji ve Biyokimya
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectTemel Tıp Bilimleri
dc.subjectBiyokimya
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectOnkoloji
dc.subjectCerrahi Tıp Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.titlePrimary central nervous system lymphoma in immunocompetent individuals: a single center experience
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume6
dc.identifier.issue6
dc.identifier.startpage1068
dc.identifier.endpage1075
dc.contributor.firstauthorID96752


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster